Диссертация (1174336), страница 30
Текст из файла (страница 30)
3587-3593.85.Bedossa, P. Dystroglican expression in hepatic stellate cells: role in liverfibrosis / P. Bedossa, S. Ferlicot, V. Paradis // Lab. Invest. – 2002. – Vol. 82, № 8. –P. 1053-1061.19686.Best practice guidance for the diagnosis and management of cysticfibrosis-associated liver-disease / D. Debray, D. Kelly, R. Houwen, B. Strandvik, C.Colombo // J. Cyst. Fibrosis.
– 2011. – Vol. 10, № 2. – P. 29-36.87.Beta 2 adrenergic receptor polymorphisms in cystic fibrosis / M.A. Hart,M.W. Konstan, R.J. Darrah M.D., Schluchter, A. Storfer-Isser, L. Xue, D. Londono,K.A. Goddard, M.L. Drumm // Pediatr. Pulmonol. – 2005. – Vol. 39, № 6. – P. 544550.88.Beta2 adrenoreceptor gene polymorphisms in cystic fibrosis lung disease/ R. Buscher, K.J. Eilmes, H. Grasemann, B. Torres, N.
Knauer, K. Sroka, P.A. Insel,F. Ratjen // Pharmacogenetics. – 2002. – Vol. 12, № 5. – P. 347-353.89.Beta-2-adrenergic receptor polymorphisms in cystic fibrosis / W.K.Steagall, B.J. Barrow, C.G. Glasgow, J.W. Mendoza, M. Ehrmantraut, J.P. Lin, P.A.Insel, J. Moss // Pharmacogenet.
Genomics. – 2007. – Vol. 17, № 6. – P. 425-430.90.Beydon, N. An official American Thoracic Society/European RespiratorySociety statement: pulmonary function testing in preschool children / N. Beydon, S.D.Davis, E. Lombardi // Am. J. Respir. Crit. Care Med. – 2007.
– Vol. 175, № 12. –P.1304-1345.91.Blombäck, B. Fibrinopeptides and fibrin gel structure / B. Blombäck, N.Bark // Biophys. Chem. – 2004. – Vol. 112, № 1-2. – P. 147-151.92.Bonow, R. ACC/AHA 2006. Guideline for the Management of Patientwith Valvular Heart Disease. А report of the American College of Cardiology. / R.Bonow, B. Carabello, K.
Chatterjee // J. Am.Coll. Cardiol. – 2006. – Vol. 48 (3). –e1-148.93.Bosman, F.T. Functional structure and composition of the extracellularmatrix / F.T. Bosman, I. Stamenkovic // J. Pathol. – 2003. – Vol. 200, № 4. – P. 423428.94.Bouwman, L.H. Mannose-binding lectin: clinical implications forinfection, transplantation, and autoimmunity / L.H.
Bouwman, B.O. Roep, A. Roos //Hum. Immunol. – 2006. – Vol. 67, № 4–5. – P. 247-256.19795.Brodsky, B. Molecular structure of the collagen triple helix / B. Brodsky,A.V. Persikov // Adv. Protein Chem. – 2005. – Vol. 70. – P. 301-339.96.Bronchiectasis in systemic sclerosis. A study using high resolutioncomputed tomography / A.P.
Andonopoulos, S. Yarmenitis, P. Georgiou, A. Bounas,C. Vlahanastasi // Clin. Exp. Rheumatol. – 2001. – Vol. 19, № 2. – P. 187-190.97.Brunt, M.E. Grading and staging the histopathological lesions of chronichepatitis: The Knodell histology activity index and beyond. / M.E. Brunt // Hepatology.– 2000. – Vol.
31 (1). – Р. 241-246.98.Burrows, N.P. The molecular genetics of the Ehlers-Danlos syndrome /N.P. Burrows // Clin. Experim. Dermatol. – 1999. – Vol. 24, № 2. – P. 99-106.99.Castellani, C.H. Consensus on the use and interpretation of cystic fibrosismutation analysis in clinical practice / C.H.
Castellani, M. Cuppens, Jr. Macek // J.Cyst. Fibr. – 2008. – Vol. 8. – P. 179-196.100. Cauwe, B. The biochemical, biological, and pathological kaleidoscope ofcell surface substrates processed by matrix metalloproteinases / B. Cauwe, P.E. Vanden Steen, G. Opdenakker // Crit. Rev. Biochem. Mol.
Biol. – 2007. – Vol. 42, № 3.– P. 113-185.101. Characteristic multiorgan pathology of cystic fibrosis in a long-livingcystic fibrosis transmembrane regulator knockout murine model / P.R. Durie, G. Kent,M.J. Phillips, C.A. Ackerley // Am. J. Pathol. – 2004. – Vol. 164, № 4. – P.1481=1493.102. Clinical phenotypes of respiratory syndrome in patients with connectivetissue dysplasia / M.V. Vershinina, G.I.
Nechaeva, L.M. Grinberg, A.A. Khomenya,S.E. Govorova // Russian Pulmonology. – 2013. – № 6. – P. 21-26.103. Cohen, M. Bronchiectasis in systemic diseases / M. Cohen, S.A. Sahn //Chest. – 1999. – Vol. 116, № 4. – P. 1063-1074.104. Cockcroft D.W. Eosinophilic bronchitis as a cause of cough /D.W.Cockcroft // Chest.- 2000.- Vol.118.- P.277.105.
Collagen content and growth factor immunoexpression in uterine lowersegment of type IA osteogenesis imperfecta: Relationship with recurrent uterine198rupture in pregnancy / A. Di Lieto, F. Pollio, M. De Falco, F. Iannotti, M. Mascolo, P.Somma, S. Staibano // Am. J. Obstet. Gynecol. – 2003. – Vol. 189, № 2. – P. 594-600.106. Collagens at a glance / K.E. Kadler, C. Baldock, J. Bella, R.P. BootHandford // J. Cell Sci. – 2007. – Vol. 120, № 12. – P. 1955-1958.107. Complex two-gene modulation of lung disease severity in children withcystic fibrosis / R.
Dorfman, A. Sandford, C. Taylor, B. Huang, D. Frangolias, Y.Wang, R. Sang, L. Pereira, L. Sun, Y. Berthiaume, L.C. Tsui, P.D. Paré, P. Durie, M.Corey, J. Zielenski // J. Clin. Invest. – 2008. – Vol. 118, № 3. – P. 1040-1049.108. Constantin, A. Stromelysin 1 (matrix metalloproteinase 3) and HLADRB1 gene polymorphisms – association with severity and progression of rheumatoidarthritis in a prospective study / A. Constantin, V. Lauwers-Cancès, F. Navaux //Arthritis Rheum.
– 2002. – Vol. 46, № 7. – P. 1754-1762.109. Cruz-Munoz, W. The role of tissue inhibitors of metalloproteinases intumorigenesis and metastasis / W. Cruz-Munoz, R. Khokha // Crit. Rev. Clin. Lab. Sci.– 2008. – Vol.45, № 3. – P. 291-338.110.
Cystic fibrosis. Liver and biliary disease in cystic fibrosis. / Third editionby M. Hudson, G. Duncan, A. Bush. – London: Edward Arnold (Publishers) Ltd, 2007.– 477 pp.111. Davidson, A.G.F. Gаstrointestinal and pancreatic disease in cystic fibrosis/ A.G.F.
Davidson // Cystic fibrosis. / Ed. by M.E. Hodson and D.M. Geddes. –London, UK, 1995. – P. 261-283.112. Deficiency of the mannan-binding lectin pathway of complement and pooroutcome in cystic fibrosis: bacterial colonization may be decisive for a relationship /M. Carlsson, A.G. Sjoholm, L. Eriksson, S. Thiel, J.C. Jensenius, M. Segelmark, L.Truedsson // Clin. Exp. Immunol. – 2005. – Vol. 139, № 2. – P.
306-313.113. Development and validation of a small single-domain antibody thateffectively inhibits matrix metalloproteinase 8 / D. Demeestere, E. Dejonckheere, S.Steeland, P. Hulpiau, J. Haustraete, N. Devoogdt, R. Wichert, C. Becker-Pauly, VanE. Wonterghem, S. Dewaele, G. Van Imschoot, J. Aerts, L. Arckens, Y.
Saeys, C.Libert, R.E. Vandenbroucke // Mol. Ther. – 2016. – Vol. 24, № 5. – P. 890-902.199114. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease/ I.P. Van de Peppel, A. Bertolini, J.W. Jonker, FA.JA. Bodewes, H.J. Verkade // CurrOpin Pulm Med. – 2017. – Vol. 23, № 6. – Р. 562- 569.115. Diagnostic Problems of Mucoviscidosis and Ways of Solution in Russia /A.A. Baranov, N.I. Kapranov, N.Y. Kashirskaya et al.
// Pediatric pharmacology. –2014. – Vol. 11 (6). – Р. 16–23.116. Disease-specific reference equations for lung function in patients withcystic fibrosis / M. Kulich M., Rosenfeld, J. Campbell, R. Kronmal, R.L. Gibson, C.H.Goss, B. Ramsey //Am J Respir Crit Care Med. – 2005.
– Vol. 172, № 7. – P. 885-891.117. Dougherty, K.A. Suboptimal vitamin K status despite supplementation inchildren and young adults with cystic fibrosis / K.A. Dougherty, J.I. Schall, V.A.Stallings // Am J Clin Nutr. – 2010. – Vol. 92, № 3. – Р. 660-667.118. ECFSPR European Cystic Fibrosis Society Patient Registry / A.
Renti, A.Zolin, L. Naehrlich, J. Van Rens et al. // Annual data report (year 2016) version 1. –2018. – 15 р.119. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lungfunction growth / F.D. Gilliland, W.J. Gauderman, H. Vora, E. Rappaport, L. Dubeau// Am. J. Respir. Crit. Care Med. – 2002. – Vol. 166, № 5. – P. 710-716.120. Eisen, D.P. Impact of mannose-binding lectin on susceptibility toinfectious diseases / D.P. Eisen, R.M. Minchinton // Clin.
Infect. Dis. – 2003. – Vol.37, № 11. – P. 1496-1505.121. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndromepatients with tenascin-X mutations / M.C. Zweers, W.B. Dean, T.H. van Kuppevelt, J.Bristow, J. Schalkwijk // Clin. Gen. – 2005. – Vol. 67, № 4. – P. 330-334.122. Emilin, a component of elastic fibers preferentially located at the elastinmicrofibrils interface / G.M. Bressan, D.
Daga-Gordini, A. Colombatti, I. Castellani,V. Marigo, D. Volpin // J. Cell Biol. – 1993. – Vol. 121, № 1. – P. 201-212.123. Expression of laminin chains in skin in merosin-deficient congenitalmuscular dystrophy / C.A. Sewry, M. D'Alessandro, L.A. Wilson, L.M. Sorokin, I.200Naom, S. Bruno, A. Ferlini, V. Dubowitz, F.
Muntoni // Neuropediatrics. – 1997. –Vol. 28, № 4. – P. 217-222.124. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosainfection in patients with cystic fibrosis / V. De Rose, C. Arduino, N. Cappello, R.Piana, P. Salmin, M. Bardessono, M. Goia, R. Padoan, E. Bignamini, D. Costantini, G.Pizzamiglio, V. Bennato, C. Colombo, A. Giunta, A. Piazza // Eur. J.
Hum. Genet. –2005. –Vol. 13, № 1. – P. 96-101.125. Features of Severe Liver Disease With Portal Hypertension in PatientsWith Cystic Fibrosis / J.R. Stonebraker, C.Y. Ooi, R.G. Pace, H. Corvol, M.R.Knowles, P.R. Durie, S.C. Ling // Clin Gastroenterol Hepatol. – 2016.
– Vоl. 14, № 8.– P.1207-1215.126. Fibrillin microfibrils / C.M. Kielty, M.J. Sherratt, A. Marson, C. Baldock// Adv. Protein Chem. – 2005. – Vol. 70. – P. 405-436.127. Five-year follow-up of 665 Hungarian patients with undifferentiatedconnective tissue disease (UCTD) / E. Bodolay, Z. Csiki, Z. Szekanecz, T. Ben, E.Kiss, M. Zeher G., Szucs, K. Danko, G. Szegedi // Clin. Exp.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
